Table 1.
Demographic data and clinical scores
| Demographic information | LBD-VH (n = 25) | LBD-NVH (n = 17) | Statistics | ||
|---|---|---|---|---|---|
| Age | 73.52 | ±6.17 | 74.06 | ±6.18 | P = 0.949a |
| Male/female | 24/1 | 13/4 | P = 0.055b (d.f. = 1) | ||
| DLB/PDD | 11/14 | 7/10 | P = 0.856b (d.f. = 1) | ||
| MMSE | 23.04 | ±3.78 | 24.88 | ±4.08 | P = 0.067a |
| Duration of dementia, years | 2.1 | ±3.3 | 4.4 | ±5.6 | P = 0.253a |
| NPI hall number | 1.56 | ±0.87 | 0 | 0 | – |
| NPI hall frequency | 2.08 | ±1.04 | 0 | 0 | – |
| NPI hall severity | 1.12 | ±0.33 | 0 | 0 | – |
| NPI hall distress | 0.92 | ±1.22 | 0 | 0 | – |
| NPI hall total (frequency × severity) | 2.44 | ±1.66 | 0 | 0 | – |
| Complex VH (yes/no) | 21/4 | – | – | ||
| Duration of VH, years | 2.2 | ±1.3 | – | – | |
| UPDRS-III | 24.16 | ±14.27 | 24.59 | ±16.69 | P = 0.644a |
| ACheI (yes/no) | 22/3 | 10/6c | P = 0.076b (d.f. = 2) | ||
| LEDD | 540 | ±482 | 540 | ±497 | P = 0.500a |
Values in the table are reported as mean ± standard deviation. d.f. = degrees of freedom; LEDD = levodopa equivalent daily dose; UPDRS-III = Unified Parkinson’s Disease Rating Scale part III.
a
Unpaired Mann–Whitney U-test (one-tailed for MMSELBD-VH < MMSELBD-NVH).
b
χ2 test.
c
One PDD patient was on memantine.